Neonatal Respiratory Support Innovations for Reducing Bronchopulmonary Dysplasia in Preterm Infants

Abstract

Background:
Bronchopulmonary dysplasia (BPD) is still a major complication of respiratory support in preterm infants. Neonatal respiratory care has developed to minimize lung injury while still providing adequate oxygenation and ventilation.
Objectives:
To assess the impact of recent developments in neonatal respiratory support on the incidence and severity of BPD in preterm infants.

Methodology:
A review of current clinical studies published from 2020 to 2025 was performed. Data on noninvasive ventilation strategies, high-flow nasal cannula therapy, synchronized ventilation, volume-targeted ventilation, and minimally invasive surfactant administration were analyzed.

Findings:
Studies showed that early application of continuous positive airway pressure (CPAP) with minimally invasive surfactant therapy was associated with a reduction in BPD incidence by approximately 18–25% compared with standard mechanical ventilation. Volume-targeted ventilation decreased ventilator-associated lung injury and shortened duration of respiratory support by a mean of 4.2 days. Furthermore, the synchronised non-invasive ventilation improved respiratory outcomes and reduced the need for intubation by nearly 20%. The combined innovations improved pulmonary development and reduced rates of chronic respiratory morbidity.

Conclusion:

Innovative strategies in respiratory support significantly reduce the risk of BPD in preterm infants by limiting lung injury and promoting gentle ventilation. More use of evidence-based non-invasive methods can improve neonatal outcomes and reduce long-term respiratory complications.